Long-acting somatostatin analogue treatments in autosomal dominant polycystic kidney disease and polycystic liver disease : a systematic review and meta-analysis

Griffiths, J. orcid.org/0000-0001-6429-8131, Mills, M.T. and Ong, A.C. orcid.org/0000-0002-7211-5400 (2020) Long-acting somatostatin analogue treatments in autosomal dominant polycystic kidney disease and polycystic liver disease : a systematic review and meta-analysis. BMJ Open, 10 (1). e032620.

Abstract

Metadata

Authors/Creators:
Copyright, Publisher and Additional Information: © 2020 The Authors. This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.
Keywords: adult nephrology; chronic renal failure; dialysis; genetics; hepatology; nephrology
Dates:
  • Accepted: 13 December 2019
  • Published: 9 January 2020
Institution: The University of Sheffield
Academic Units: The University of Sheffield > Sheffield Teaching Hospitals
Depositing User: Symplectic Sheffield
Date Deposited: 27 Jan 2020 10:31
Last Modified: 27 Jan 2020 10:31
Status: Published
Refereed: Yes
Identification Number: https://doi.org/10.1136/bmjopen-2019-032620

Download

Share / Export

Statistics